Article Details
Retrieved on: 2024-11-29 11:57:52
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article describes Virpax Pharmaceuticals, Inc.'s SEC Form 8-K filing, relating to amendments in their bylaws. This connects to capital markets as it involves regulatory compliance with SEC regulations like the Securities Act and Exchange Act.
Article found on: quantisnow.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here